Olivia Esposito • February 5, 2024
Yale New Haven Hospital Heart and Vascular Center – New Haven, CT

Yale New Haven Hospital Heart and Vascular Center offer multidisciplinary services from the latest imaging techniques and genetic profiling of HCM to advanced diagnostic testing, treatment options, and clinical trials – all with an emphasis on compassion and communication.

Yale New Haven’s well-established HCM center provides specialized, expert physicians and staff specially trained to manage HCM. This multidisciplinary team has the experience necessary to provide seamless care to patients and their families at every age and stage of this disease. Yale has three Co-Directors of the HCM Program: Dr. Rachel Lampert, Dr. John Stendahl, and Dr. Sounok Sen.

The HCM team includes specialists in:

  • Adult and Pediatric Cardiology
  • Advanced Heart Failure Cardiology
  • CardiacaAesthesia
  • Cardiac Electrophysiology
  • Cardiac Genetics
  • Cardiac Imaging
  • Cardiac Surgery
  • Cardio-Obstetrics
  • Interventional Cardiology
  • Nutrition
  • Research
  • Social Work

Services include medical management, genetic counseling, family screening, advanced management of heart rhythm disorders, catheter-based procedures, and surgical interventions when necessary. Yale New Haven HCM Team provides clinical trial access and monthly support group meetings.

The Yale New Haven HCM Team recently participated in our BigHearted Warriors Unite Webinar Series. If you would like to watch team members Dr. Rachel Lampert, Dr. John Stendahl,  Dr. Sounok Sen, Dr.Arya Mani, and Dr. Nikhil Sikand’s free Bighearted Warriors education webinar, please visit  https://www.youtube.com/live/xXvmdTJNxKQ?si=oFRIw70lYUmM-FL6.

For more information on the Yale New Haven HCM Program in New Haven, CT, please visit:  https://4hcm.org/yale/


For more information on all HCMA-recognized centers of excellence, please visit  https://4hcm.org/center-of-excellence/.

HCMA Blog

By Lisa Salberg July 3, 2025
Summer, greetings to all our big-hearted friends As July approaches, our focus is already on the fall and preparing for some major events, including our annual meeting coming up in October. July will also find us on the west coast in Seattle conducting a regional patient education meeting as part of our big-hearted warrior tour. We have been following the generic drug quality issue in the United States very closely and encourage you to watch the series starting with our Hill briefing in April and following with the additional webinars with our partners at Medshadow and the People's Pharmacy, and of course the ProPublica series of articles. See them all here . We are happy to have a new team member on board - we welcome Pam as our coordinator of both our All Hearts Collaborative and Hearts and Minds project. Over the next few months, you're going to be learning more about these two amazing initiatives and how we are working to provide better services for big hearts regardless of where you live, so we are meeting all of our big-hearted friends where they are. Please stay tuned for updates from these projects coming soon. We are also creating new volunteer opportunities and engagements that we hope will make it easier for you to participate in spreading the message of the importance of diagnosis, the importance of community readiness related to CPR and AED use and, of course, helping patients get to their ultimate diagnosis and getting them on the proper treatment pathways. This July I would like to recognize all of the special birthdays in my family, including HCMA Center of Excellence coordinator, Stacey Titus-brown and my daughter Rebecca Salberg. It's a milestone birthday for Becca - it’s hard to believe I have a 30-year-old child. Wishing you all a happy and healthy summer. Go build some memories!
An official seal in black  & red with white letters that say HCMS Recognized Centers of Excellence
By Sabrina Cuddy July 3, 2025
Getting HCM care at a HCMA Recognized Center of Excellence has a positive impact on patient's outcomes. Find out why in the post by Health Educator Sabrina Cuddy
By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
More Posts